On Tuesday, August 31 the Foundation hosted its annual Corporate Partners Reception. For over 30 years, the Henry Mayo Newhall Hospital Corporate Partners Program has connected the business community to our community Hospital. Our Corporate Partners annual giving commitment provides much-needed support to our patient care programs, including our Emergency Department and Trauma Services and our Center for Women and Newborns.
This year’s event featured presentations about new and exciting innovations at the Roberta G. Veloz Cardiovascular Center. Under the leadership of CEO, Roger Seaver, a philanthropic expression of gratitude by Roberta G. Veloz nearly a decade ago was instrumental in giving rise to Henry Mayo's cardiovascular services.
Jennifer Whitcomb, RN, Clinical Manager highlighted many of the accomplishments achieved by our cardiovascular center over the past few years. James S. Lee, MD, Medical Director, Cardiac Cath Lab and Abhishek Sinha, MD, Medical Director, Structural Heart Program gave presentations on the STEMI program and the new TAVR procedure.
Dr. Lee stressed of the importance of having a state-of-the-art cardiac cath lab in the Santa Clarita Valley. “According to the CDC, every 40 seconds someone is having a heart attack. When we analyze the data, the Santa Clarita Valley community has a complexity of cardiac arrest cases that are 2-3 times higher than the national average.” It was an amazing accomplishment for the entire team when in 2020, Henry Mayo’s STEMI (ST- Elevation Myocardial Infarction) Receiving Center (SRC) was recognized for an outstanding “Door-to-PCI” time averaging 45 minutes, which is significantly faster than the national standard of 60 minutes.
In June of this year, Henry Mayo recently began offering the TAVR procedure which is a minimally-invasive cutting-edge heart procedure to replace narrowed aortic valves that fail to open properly. Dr. Sinha was one of the first local interventional cardiologists to begin performing TAVRs and he’s completed 175 successful procedures, six of which were recently performed at Henry Mayo.
Dr. Sinha stated that “Over the last decade, the TAVR procedure has revolutionized the way that we treat heart disease. The TAVR began as a procedure for high-risk patients only, but as improvements were made, it has now become the most common way to replace the aortic valve procedure.”
We want to Thank All of our Corporate Partners for their generosity and continued support of our community hospital.
Please consider joining our Corporate Partners Program. For more information, please call 661-200-1200, or visit here.